治疗耐药EGFR抑制剂诱导的乳腺瘤疹治疗与异丁氨酸和达普森
Ishana Dixit1,2, Raquel Ruiz Araujo1,2, Pablo Fernandez-Peñas1,2
1Department of Dermatology, Westmead Hospital, New South Wales, Australia.
The Australasian journal of dermatology
|March 10, 2026
概括
伊索特里诺因和达普松有效地控制了EGFRi诱导的抗性皮疹,而伊索特里诺因显示出更快的结果. 维持癌症治疗与皮肤病治疗一起,可以改善结果和生存率.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮表皮生长因子受体抑制剂 (EGFRi) 常常会导致乳头状外血瘤,可能会破坏癌症治疗.
- 对于这些爆发,四环素是标准的,但对耐火病例的替代方法不太了解.
研究的目的:
- 为了比较异氨酸与达普松在控制EGFRi诱导的抗四环素抗性乳头疹的疗效和耐受性.
- 评估治疗结果,反应时间和接受异丁或达普森的患者的不良事件.
主要方法:
- 对16名因EGFRi诱导的乳头疹喷发 (2018-2024) 接受异丁氨酸或达普松治疗的患者进行了回顾性审查.
- 收集的数据包括人口统计数据,恶性瘤,EGFRi代理物,喷发严重程度,先前的治疗方法,医生的全球评估,结果,反应时间,不良事件和EGFRi剂量修改.
- 统计分析采用单向ANOVA和千平方/费舍尔精确测试进行群组比较.
主要成果:
- 伊索特里诺因组的发病严重程度较高;然而,与达普森 (21.0周) 相比,最佳反应的时间较短 (14.9周).
- 完整解消率为异二胺62.5%和达普松50%;这两种药物都被耐受良好.
- 继续EGFRi治疗的患者 (有或没有减少剂量) 的生存率高于停止治疗的患者.
结论:
- 伊索特里诺因和达普松是对抗四环素耐药EGFRi诱导的乳腺突喷发的有效,耐受性良好的选择.
- 伊索特里诺因表现出更快的症状改善趋势,整体反应率与达普森相似.
- 持续的EGFRi治疗,支持皮肤管理,对于维持瘤治疗和改善患者的治疗结果和生存是至关重要的.
相关概念视频
Pulmonary Tuberculosis V
719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
629
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
629
Peptic Ulcer Disease IV: Management
601
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
601
Drug Toxicity: Allergic Reactions
84
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
84
Rheumatic Heart Disease III: Medical Management
445
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
445


